DUBLIN--(BUSINESS WIRE)--The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides - 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
'Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides - 2023 to 2027'
Will all newborns receive genetic testing at birth? What segments are growing fastest? Where are the opportunities now that sequencing has gone mainstream?
The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out for five years. The report includes detailed breakouts for 14 countries and 5 regions. Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years. The Global Market for Human Genome Sequencing
Global Market Overview by Country
Global Market by Application - Overview
Global Market by Technology - Overview
Global Market by Workflow - Overview
Global Market by Product - Overview
Market Sizes by Application
Hereditary Gene Sequencing Market
NIPT Gene Sequencing Market
WGES Gene Sequencing Market
DTC Gene Sequencing Market
Research Gene Sequencing Market
Market Sizes by Technology
Software & Services Market
Vision of the Future of Human Gene Sequencing
1.1 Human Gene Sequencing Markets - Strategic Situation Analysis & COVID Impact 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 Gene Sequencing Definition In This Report
2.1.3 Non Invasive Prenatal Testing
2.2 The Genomics Revolution
2.3.1 Revenue Market Size
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.4 Genetic Testing vs. Gene Sequencing
2.6.5 Cost and Pricing Practice
3 Global Listing of Sequencer Installed Base - Location & Contacts
3.1 Notes to Installed Base Listing
3.2 Illumina Installed Base
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.11 Certification Body
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.1.1 Clinical and Research Lines Blur
4.2.1.2 Genetic Counselling - Not so simple anymore
4.2.1.3 The Genetic Blizzard - Issues of Access and Payment
4.2.2 Newborn Screening - The Standard of Care
4.2.2.1 Newborn Screening - Do Parents Want to Know?
4.2.3 NIPT - We've Only Just Begun
4.2.3.1 NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
4.2.4 Oncology - Understanding Two Worlds
4.2.4.1 The Tumor - A Sequence of Sequencing 4.2.4.2 The Tumor - Biopsy and Liquid Biopsy 4.2.4.3 The Human Genome - Predisposition and Prognosis
4.2.5.1 Sequencing Not the Only Player
4.2.5.2 New Roles for Old Drugs - A Research Bonanza?
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3.1 Hospital's Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization
5.1 Factors Driving Growth
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer - Screening, Management and Monitoring 5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
5.3.1 Instrumentation Tenacity
5.3.2 Declining Cost of Instruments Changes Industry Structure
5.3.3 Long Reads - Further Segmentation
6 Human Gene Sequencing Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Natera Files Suit Against NeoGenomics 6.3 Genomics England to Sequence 100K Newborns
6.4 Novigenix Raises $14M for NGS based Liquid Biopsy 6.5 LetsGetChecked Launching New PGx Service
6.6 Qiagen, Neuron23 Partner for NGS Diagnostic
6.9 Dante Labs to Introduce WGS to Italian Healthcare System 6.11 Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
6.13 Oncocyte and Thermo Fisher Strike Partnership Deal 6.14 Illumina Partners With Precision Medicine to Assess Liquid Biopsy 6.17 Strata Oncology Trial Supports NGS Assay
6.18 NYU Gets FDA Clearance for Sequencing Test 6.19 NeoGenomics to Acquire Inivata
6.21 Cancer Heritability Gene Set Expanded 6.22 Whole-Genome Sequencing Could Replace Cytogenetics
6.24 Ancestry Shutters Health Offering
6.25 Genetron Health Targeting Early Cancer Detection 6.26 Pan-European Initiative to Build Tools for Sharing Genomic Data
6.28 Foundation Medicine Liquid Biopsy Gets FDA Approval
6.29 American Heart Association Develops Genetic Testing Guidelines
6.30 Yourgene Health Gets CE Mark for Iona NIPT Test
6.31 NorthShore Looks to Expand Genomics Integration Into Primary Care
6.32 Germline Results From Tumor Sequencing Guides Precision Therapy 6.33 FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics 6.34 BillionToOne Closes $15M Series A Follow-on Round
6.35 Clinics to Integrate Genomics Into Primary Care
United States Medicare System: January 2022 laboratory Fees Schedule
The Whole Genome Sequence of SARS-CoV-2
Profiles of Key Companies
Baylor Miraca Genetics Laboratories
Complete Genomics, Inc. - A BGI Company
Genomics Personalized Health (GPH)
Novogene Bioinformatics Technology Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/nqo2do
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.